​

ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

ANI Pharmaceuticals Ownership Summary


ANI Pharmaceuticals is owned by 109.23% institutional investors, 5.42% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.92% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.33% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockANI Pharmaceuticals109.23%5.42%-14.65%
SectorHealthcare Stocks 129.40%12.08%-41.48%
IndustrySpecialty & Generic Drug Manufacturers Stocks36.62%14.07%49.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de3.16M14.92%$229.27M
Blackrock2.66M13.91%$169.17M
Vanguard group1.31M6.50%$103.02M
State street950.97K4.49%$69.09M
American century companies912.65K4.31%$66.30M
Vanguard capital management904.71K4.28%$65.73M
Soleus capital management867.76K4.15%$71.83M
Dimensional fund advisors lp728.75K3.44%$52.94M
Tang capital management707.50K3.38%$58.57M
Ubs group621.34K2.94%$45.14M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management707.50K2.66%$58.57M
Soleus capital management867.76K2.48%$71.83M
Ikarian capital272.08K2.43%$22.52M
Ranger investment management268.63K1.83%$19.52M
Parkman healthcare partners202.91K1.72%$16.80M
Sio capital management97.31K1.33%$8.05M
Globeflex capital l p108.57K1.15%$8.99M
Penn capital management company213.25K1.13%$15.52M
Marathon capital management71.81K1.07%$5.22M
Aurora investment counsel26.69K1.00%$1.94M

Top Buyers

HolderShares% AssetsChange
American century companies912.65K0.03%338.17K
Ubs group621.34K0.01%323.80K
Victory capital management345.50K0.01%305.49K
Rubric capital management lp258.13K0.20%258.13K
Divisadero street capital management, lp234.22K0.94%234.22K

Top Sellers

HolderShares% AssetsChange
Goldentree asset management lp---667.98K
Deep track capital, lp---600.00K
Global alpha capital management---558.00K
Sixth street partners management company---252.57K
Jones hill capital lp---233.81K

New Positions

HolderShares% AssetsChangeValue
Rubric capital management lp258.13K0.20%258.13K$21.37M
Divisadero street capital management, lp234.22K0.94%234.22K$21.45M
Cubist systematic strategies44.14K0.02%44.14K$4.04M
Empowered funds32.34K0.01%32.34K$2.35M
Two sigma advisers, lp24.50K0.00%24.50K$2.24M

Sold Out

HolderChange
Davis capital management-1.00
Huntington national bank-1.00
Nelson, van denburg & campbell wealth management group-1.00
Financial gravity asset management-1.00
Mendota financial group-1.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2026298-5.40%23,110,916-0.46%1090.91%1751.16%79-12.22%
Jun 30, 20263128.71%23,177,347-0.92%1100.81%17212.42%893.49%
Mar 31, 2026132-54.79%6,340,720-70.04%310.28%71-56.97%36-52.63%
Dec 31, 202583-69.71%3,388,014-83.40%160.16%37-74.66%27-67.86%
Sep 30, 202599-55.61%3,677,102-80.25%180.21%49-57.76%29-57.97%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.21M5.33%-2.77K
Avantis US Small Cap Value ETF809.08K3.56%7.17K
Vanguard MStar Total Stk Mkt Idx Invest656.41K2.86%41.79K
Vanguard US Total Market Shares ETF588.25K2.73%-
Vanguard Morn Total Stk Mkt Idx Investor609.43K2.68%8.50K
Vanguard Total Stock Mkt Idx Inv609.43K2.68%8.50K
Pacer US Small Cap Cash Cows 100 ETF549.63K2.62%-1.87K
iShares Russell 2000 ETF515.63K2.27%-
Delaware Ivy Small Cap Growth C336.40K1.60%-
Macquarie Small Cap Growth C264.83K1.22%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 13, 2026Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$35.40K
Oct 29, 2026CAREY STEPHEN P. SVP & CFOSell$207.68K
Oct 15, 2026Lalwani Nikhil PRESIDENT & CEOSell$388.21K
Oct 13, 2026Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$36.80K
Sep 29, 2026CAREY STEPHEN P. SVP & CFOSell$208.05K

Insider Transactions Trends


DateBuySell
2026 Q4-4
2026 Q3-11
2026 Q2-11
2026 Q1-18
2025 Q4-8

ANIP Ownership FAQ


Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 109.23%, followed by 5.42% insiders and -14.65% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 36.62%, which ANI Pharmaceuticals exceeds.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock funding, inc. /de (3.16M shares, 14.92%), Blackrock (2.66M shares, 13.91%), and Vanguard group (1.31M shares, 6.50%). Together, they hold 35.33% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.66% of its assets in 707.5K ANI Pharmaceuticals shares, valued at 58.57M$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 5.33% of its total shares outstanding invested in 1.21M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools